发明名称 New carboxy-reduced and selectively O-sulfated chondroitin sulfate derivatives, useful for treating e.g. articular degeneration or disorders of bone metabolism, are inhibitors of matrix metalloproteases
摘要 Isolated or mixed carboxy-reduced and chemoselectively O-sulfated derivatives (A) of chondroitin sulfate (CS) and their salts are new. An independent claim is also included for three methods for preparing (A). ACTIVITY : Antiarthritic; Vulnerary; Analgesic; Osteopathic; Antiinflammatory; Muscular-Gen.; Antirheumatic. MECHANISM OF ACTION : Metalloprotease inhibitor. Carboxy-reduced, persulfated CS had IC50 for inhibition of aggrecanase of 0.004 Microg/ml; inhibited factor Xa only weakly (1.2 units/mg; contrast 100 units /mg for reference heparin) and had IC50 against human MMP 2 and 7 of 0.4 Microg/ml.
申请公布号 FR2864089(A1) 申请公布日期 2005.06.24
申请号 FR20030014988 申请日期 2003.12.19
申请人 AVENTIS PHARMA SA 发明人 ULMER WOLFGANG;VISKOV CHRISTIAN;HUBERT PHILIPPE
分类号 A61K31/737;A61P19/02;C08B37/08 主分类号 A61K31/737
代理机构 代理人
主权项
地址